Update on Advanced Anti-CD20 Therapeutics to Improve Outcomes for Patients with Multiple Sclerosis - AcademicCME

Update on Advanced Anti-CD20 Therapeutics to Improve Outcomes for Patients with Multiple Sclerosis

1.0

Claim your AMA PRA Category 1 Credit

Already have an Account? Log In
Don’t have an account? Register Today

Claim your Certificate

course Faculty

No data was found

Related Courses

Cardiometabolic

LIVE UPDATE FROM ACC25: More Support for the “Factor XI Hypothesis”

Cardiometabolic

MANAGEMENT OF PSVT: UPDATE FROM ACC25

Best Practices in Contract Negotiation: Knowing Your Worth as an MS Specialist